Publications
50
Citations
1,487
Est. group size
—
Recurring co-author estimate
Active years
24
Publishing since 2002
Adam Quick's work centers on amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease affecting nerve cells that control muscle movement, including clinical trials of experimental drugs, disease epidemiology, and genetic testing in ALS patients. He also has a parallel line of work in neurology medical education, focusing on training methods for medical students and residents. This profile suggests a clinician-researcher role that combines patient-oriented ALS research with efforts to improve how neurology is taught.
Publication output has fluctuated over the past decade with no clear long-term growth or decline, showing peaks around 2020, 2023, and 2025 and a low point in 2024, averaging about 3 publications per year over the last 5 years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Pridopidine in Amyotrophic Lateral Sclerosis
JAMA · 2025
- Verdiperstat in Amyotrophic Lateral Sclerosis
JAMA Neurology · 2025
- CNM-Au8 in Amyotrophic Lateral Sclerosis
JAMA · 2025
- Empowering Future Neurology Educators: Insights from the First Year of AAN’s Resident as Educator Training (S28.006)
Neurology · 2025
- Neurology Residents
Neurology Education · 2024
- Teaching neurologists through microlearning: the first 4 years of the eLearning experience with NeuroBytes (P13-2.001)
Neurology · 2023
- PREP-A Medical Student Led Initiative to Enhance Learning and Facilitate Assessment Preparation (P4-2.001)
Neurology · 2023
- Localizing Weaknesses in Pre-Clinical Neurology Education (P4-2.006)
Neurology · 2023
- Mo1050 PREP (PEER-REVIEWED EXAM PRACTICE): A STUDENT LED, FACULTY COLLABORATIVE, FORMATIVE PRACTICE MODEL TO REINFORCE MEDICAL KNOWLEDGE AND INCREASE EDUCATIONAL ACCESSIBILITY
Gastroenterology · 2023
- Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trial
Journal of Neurology Neurosurgery & Psychiatry · 2022
- The American Academy of Neurology Residents as Educators Workgroup Initiative: Nurturing future neurology educators (S34.005)
Neurology · 2022
- Adult Onset Multiple Acyl-CoA Dehydrogenase Deficiency (MADD) Diagnostic Challenge (P17-13.008)
Neurology · 2022
- Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial
The Lancet Neurology · 2021
- The Incidence of Amyotrophic Lateral Sclerosis in Ohio 2016–2018: The Ohio Population-Based ALS Registry
Neuroepidemiology · 2021
- Lyme Neuroborreliosis Masquerading as Colonic Ileus (2584)
Neurology · 2021
- Neurology×16
- Muscle & Nerve×2
- JAMA×2
- JAMA Neurology×2
- Neurology Genetics×2
- Laura A. Foster
Medicine · Indiana University
- Jinyue Li
Medicine · Purdue University West Lafayette
- Albert Lee
Medicine · Purdue University West Lafayette
- Kelly Rich
Medicine · The Ohio State University
- Sarah Heintzman
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile